Remove Embolism Remove Strokes Remove Thrombosis
article thumbnail

CircRNA-mediated regulation of cardiovascular disease

Frontiers in Cardiovascular Medicine

stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g.,

article thumbnail

Abstract 4145271: Systemic Lupus Erythematosus-Induced Libman-Sacks Endocarditis Complicated by Multiple Embolic Episodes and Atypical Secondary Valve Involvement

Circulation

A 42-year-old female with SLE, lupus cerebritis with related seizure disorder, and mesenteric venous thrombosis on warfarin initially presented for syncope. Acute stroke workup was negative, and syncope was attributed to possible brief seizure. Circulation, Volume 150, Issue Suppl_1 , Page A4145271-A4145271, November 12, 2024.

article thumbnail

Management of complications associated with percutaneous left atrial appendage closure with or without ablation: experience from 512 cases over a 4-year period

Frontiers in Cardiovascular Medicine

These included three cases of intraoperative thrombosis, three instances of pericardial effusion or tamponade, one case of device-related thrombosis, one peri-device leak, one systemic embolism, one bleeding episode, and one additional device-related complication.

article thumbnail

MP-483492-002 COMPARATIVE EFFECTIVENESS OF DIFFERENT MANAGEMENT STRATEGIES FOR LEFT ATRIAL APPENDAGE THROMBUS IN PATIENTS ON OPTIMAL NOAC THERAPY

HeartRhythm

Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Novel oral anticoagulants (NOACs) effectively reduce the prevalence of LAA thrombosis and stroke risk.

article thumbnail

Abstract 169: Antiplatelet regimens after pseudoaneurysm embolization with phosphorylcholine coated flow diverters: a series of 180 cases

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 3 The third‐generation iteration of the Pipeline Embolization Device (PED) incorporates Shield technology, a phosphorylcholine coating designed to reduce thrombogenicity via mimicry of native cell membranes.4

article thumbnail

Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease

Stroke Journal

Stroke, Volume 55, Issue 2 , Page 311-323, February 1, 2024. Intracranial atherosclerotic disease (ICAD) is one of the most common causes of stroke worldwide. In addition to stroke, ICAD increases the risk of dementia and cognitive decline, magnifying ICAD societal burden.

article thumbnail

Abstract 134: Thrombotic Complications of Ovarian Hyperstimulation Syndrome

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. There were 1,955 hospitalizations for OHSS in NIS.